Vivian Lee, PhD, President of Health Platforms, Verily Life Sciences


Vivian Lee, PhD, discusses lessons from her book, The Long Fix: Solving America's Health Care Crisis with Strategies that Work for Everyone, and from her experiences as a former CEO and dean at the University of Utah Health and now President of Verily Health Platforms (Alphabet). She discusses lessons about leading change with respect to three main key constituents in health care—patients, clinicians and payers (employers)—and explores the role of data and technology in that change.

About the Presenter

Dr. Vivian Lee is the president of Health Platforms at Verily Life Sciences. A physician and health care executive, Dr. Lee also serves as a senior lecturer at Harvard Medical School.

Prior to joining Verily, Dr. Lee served as the dean of the Medical School and CEO of the University of Utah Health Care, an integrated health system with a budget of $3.6 billion, including a 1400 member physician group and health insurance plan. During her tenure, she led the University of Utah Health to recognition for its health care delivery system innovations that enable higher quality at lower costs and with higher patient satisfaction and superior financial performance. In 2016, the University of Utah was ranked first among all university hospitals in quality and safety (Vizient). Dr. Lee previously was the inaugural Chief Scientific Officer of New York University’s Langone Medical Center.  

Elected to the National Academy of Medicine with over 200 peer-reviewed publications, Dr. Lee serves on the Board of Directors of the Commonwealth Fund, the Board of Trustees of Boston Children’s Hospital and is also a director on the board of Zions Bancorporation, a publicly-traded company.

Dr. Lee is a magna cum laude graduate of Harvard. She received a DPhil in medical engineering from Oxford University as a Rhodes Scholar, earned her MD with honors from Harvard Medical School, and her MBA from NYU. She was named by Modern Healthcare as one of the 50 Most Influential Clinical Executives in 2020.